Hudson Therapeutics, Inc. was founded in February 2023 by Shaperon Inc., a KOSDAQ-listed biotech in Korea.
The founder, Dr. Shawn Y. Seong has a successful track record for new therapeutics development and for investors with the IPO of Shaperon in October 2022, a biotech company founded in Korea in 2008.
Hudson Therapeutics, Inc. is headquartered in Research Triangle Park, NC, and has an office in Cambridge, MA
Enriching patients' quality of life is at the core of our purpose. We aim to enhance therapeutic potential through strategic innovation and adept development, ultimately contributing to patient well-being.
Hudson Therapeutics, Inc. operates at the forefront of pharmaceutical innovation. Our strategy is simple yet powerful: in-license promising assets, add value through an innovative development strategy and implementation, and out-license them to maximize their commercialization potential.
Headquarter: 15 TW Alexander Drive Durham, NC 27709, USA
Massachusetts Office: 3 Allied Drive, Suite 303, Dedham, MA 02026
Cambridge Office: 245 First Street, Riverview ll, 18th Fl, Cambridge, MA, 02142
© 2023 Hudson Therapeutics, Inc.
The information presented on this website is derived from the official website of our parent company, Shaperon, Inc. This site is designed exclusively to showcase Hudson Therapeutics, Inc. to potential investors and partners. Please note that we are not responsible for any misuse of the content outside its intended purpose.